<10>Herpesvirus deconjugases inhibit the IFN response by promoting TRIM25 autoubiquitination and functional inactivation of the RIG-I signalosome
Herpesvirus deconjugases inhibit the IFN response by promoting TRIM25 autoubiquitination and functional inactivation of the RIG-I signalosome
Soham Gupta, PaÈ ivi YlaÈ-Anttila1, Simone Callegari, Ming-Han Tsai, Henri-Jacques Delecluse, Maria G. Masucci. PLoS Pathog. (2018) 14(1):e1006852.
Speaker: Yi-Ling Soong (宋宜綾) |
Time: 13:10-14:00, Mar. 28, 2018 |
Commentator: Dr. Shun-hua Chen (陳舜華老師) |
Place: Room 601 |
Abstract
The N-terminal domains of herpesvirus large tegument proteins exhibit a conserved ubiquitin deconjugase activity and play important roles in counteracting host innate immunity.1, 2 However, studies exploring the precise counteracting mechanisms and target proteins are hampered by the difficulty to express these deconjugases with such large protein sizes. By utilizing the N-terminal catalytic domain alone of EBV deconjugase BPLF1 as a bait, the authors identified several members of the 14-3-3 protein family as major BPLF1-binding partners. Further analysis revealed that an E3 ubiquitin ligase TRIM25 forms a tri-molecule complex with BPLF1 and 14-3-3. Following previous clues that both 14-3-3 and TRIM25 promote K63-linked ubiquitination of RIG-I and RIG-I-mediated signaling3, the authors demonstrated that BPLF1 inhibits RIG-I-mediated interferon response including IRF3 activation and induction of interferon and interferon-stimulated genes. The deconjugase activity of BPLF1 is not involved in the tri-molecule interaction but is required for inhibition of RIG-I signaling. Depending on its deconjugase activity, BPLF1 promotes autoubiquitination and dimerization of TRIM25 but reduces K63-linked ubiquitination of RIG-I, which may account for the suppression of RIG-I-mediated signaling. Moreover, interaction with TRIM25 and 14-3-3 and reduction of RIG-I ubiquitination are conserved among all herpesvirus deconjugases tested. Therefore, this finding may be useful for developing a novel anti-viral treatment against a broad spectrum of herpesviruses.
References
- Van Gent M et al. Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling. PLoS Pathog. (2014) 10(2):e1003960.
- Ye R et al. Herpes Simplex Virus 1 Ubiquitin-Specific Protease UL36 Abrogates NF-κB Activation in DNA Sensing Signal Pathway. J Virol. (2017) 91(5): e02417-16
- Liu HM et al. The mitochondrial targeting chaperone 14-3-3ε regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity. Cell Host Microbe. (2012) 11(5):528-537.